The Family Firm’s Templeton Emerging Markets Fund EMF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.18M Sell
217,772
-1,204
-0.5% -$15.9K 0.77% 32
2025
Q1
$2.81M Sell
218,976
-49,731
-19% -$629K 0.63% 34
2024
Q4
$2.66M Buy
268,707
+797
+0.3% +$10.3K 0.59% 36
2024
Q3
$3M Buy
267,910
+7,115
+3% +$90.2K 0.66% 34
2024
Q2
$2.66M Buy
260,795
+49,746
+24% +$601K 0.59% 33
2024
Q1
$2.52M Buy
211,049
+4,816
+2% +$55.4K 0.61% 33
2023
Q4
$2.41M Buy
206,233
+8,590
+4% +$97.9K 0.62% 36
2023
Q3
$2.24M Sell
197,643
-2,621
-1% -$31.2K 0.63% 36
2023
Q2
$2.37M Buy
200,264
+6,763
+3% +$78.4K 0.63% 35
2023
Q1
$2.26M Buy
193,501
+15,109
+8% +$180K 0.63% 35
2022
Q4
$2.04M Buy
178,392
+6,811
+4% +$76.4K 0.6% 38
2022
Q3
$1.78M Sell
171,581
-9,887
-5% -$117K 0.57% 38
2022
Q2
$2.17M Buy
181,468
+11,197
+7% +$140K 0.64% 34
2022
Q1
$2.34M Buy
170,271
+32,316
+23% +$483K 0.61% 37
2021
Q4
$2.21M Sell
137,955
-8,198
-6% -$140K 0.57% 38
2021
Q3
$2.64M Buy
146,153
+10,580
+8% +$191K 0.69% 32
2021
Q2
$2.68M Sell
135,573
-1,281
-0.9% -$25.1K 0.73% 31
2021
Q1
$2.61M Buy
136,854
+5,332
+4% +$105K 0.75% 31
2020
Q4
$2.58M Buy
131,522
+12,600
+11% +$213K 0.77% 31
2020
Q3
$1.83M Sell
118,922
-6,104
-5% -$92.4K 0.65% 34
2020
Q2
$1.71M Buy
125,026
+6,815
+6% +$85.5K 0.64% 33
2020
Q1
$1.32M Buy
118,211
+8,906
+8% +$127K 0.56% 39
2019
Q4
$1.7M Sell
109,305
-2,993
-3% -$45.6K 0.58% 41
2019
Q3
$1.65M Buy
112,298
+769
+0.7% +$11.4K 0.58% 39
2019
Q2
$1.68M Buy
111,529
+6,640
+6% +$98.7K 0.6% 38
2019
Q1
$1.56M Buy
104,889
+9
+0% +$130 0.57% 40
2018
Q4
$1.38M Sell
104,880
-977
-0.9% -$13.3K 0.55% 40
2018
Q3
$1.55M Buy
105,857
+15,302
+17% +$223K 0.56% 40
2018
Q2
$1.33M Buy
90,555
+8,559
+10% +$133K 0.5% 40
2018
Q1
$1.33M Sell
81,996
-1,679
-2% -$28.6K 0.52% 41
2017
Q4
$1.37M Buy
83,675
+9
+0% +$152 0.54% 37
2017
Q3
$1.38M Buy
83,666
+541
+0.7% +$8.7K 0.58% 35
2017
Q2
$1.24M Sell
83,125
-19,573
-19% -$288K 0.55% 38
2017
Q1
$1.44M Sell
102,698
-10,971
-10% -$145K 0.69% 31
2016
Q4
$1.37M Sell
113,669
-686
-0.6% -$8.38K 0.65% 33
2016
Q3
$1.44M Sell
114,355
-12,888
-10% -$159K 0.69% 32
2016
Q2
$1.45M Buy
127,243
+5,103
+4% +$55.8K 0.72% 29
2016
Q1
$1.32M Buy
122,140
+33,216
+37% +$323K 0.67% 31
2015
Q4
$887K Buy
88,924
+18,580
+26% +$212K 0.47% 44
2015
Q3
$776K Buy
70,344
+18,074
+35% +$225K 0.42% 43
2015
Q2
$761K Buy
52,270
+4,095
+9% +$63.6K 0.39% 42
2015
Q1
$735K Buy
48,175
+1,519
+3% +$23.6K 0.37% 43
2014
Q4
$719K Buy
+46,656
New +$786K 0.37% 45

Other funds holding EMF

The Family Firm's EMF Position: Q2 2025 in Review

The Family Firm reduced its Templeton Emerging Markets Fund (EMF) stake by 0.55% in Q2 2025, selling an estimated $15.9K and leaving 217,772 shares worth $3.18M. The position accounts for 0.77% of the portfolio, ranked #32.

The Family Firm first reported a position in EMF in Q4 2014 and has held it in 43 quarters since. 58 funds tracked by Wall St. Rank hold EMF as of Q2 2025.

  • The Family Firm held 217,772 shares of Templeton Emerging Markets Fund worth $3.18M as of Q2 2025.
  • The Family Firm sold 1,204 Templeton Emerging Markets Fund shares in Q2 2025, an estimated $15.9K.
  • Templeton Emerging Markets Fund made up 0.77% of The Family Firm's portfolio in Q2 2025, its #32 holding.
  • The Family Firm first reported a position in Templeton Emerging Markets Fund in Q4 2014 and has held it in 43 quarters since.
  • 58 funds tracked by Wall St. Rank held Templeton Emerging Markets Fund as of Q2 2025.

Based on The Family Firm's 13F filing for Q2 2025, filed 8 Aug 2025.